aminolevulinic acid has been researched along with Leukemia, Myeloid, Acute in 5 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "By determining cell viability using tetrazolium salt reduction (MTT), by flow cytometrypropidium iodide assay and by determining cell proliferation using bromodeoxyuridine incorporation we studied the effect of photodynamic therapy based on the application of 5-aminolevulinic acid on the cells of leukemic cell lines HL60 (human promyelocytic leukemia), HEL (erythroleukemia), DAUDI (B-cell leukemia), JURKAT (T-cell lymphoma), blast cells of patients with acute myelogenous leukemia as well as on normal lymphocytes and normal human bone marrow progenitors." | 3.70 | [Selective photodynamic destruction of leukemic cells]. ( Bartosová, J; Cajthamlová, H; Grebenová, D; Hrkal, Z; Klamová, H; Marinov, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olcay, L | 1 |
| Hazirolan, T | 1 |
| Yildirmak, Y | 1 |
| Erdemli, E | 1 |
| Terzi, YK | 1 |
| Arda, K | 1 |
| Oztürkmen, S | 1 |
| Akyay, A | 1 |
| Kaymak-Cihan, M | 1 |
| Biçakçi, Z | 1 |
| Bal, C | 1 |
| Fukuchi, Y | 1 |
| Miyakawa, Y | 1 |
| Kizaki, M | 1 |
| Umezawa, A | 1 |
| Shimamura, K | 1 |
| Kobayashi, K | 1 |
| Kuramochi, T | 1 |
| Hata, J | 1 |
| Ikeda, Y | 1 |
| Tamaoki, N | 1 |
| Nomura, T | 1 |
| Ueyama, Y | 1 |
| Ito, M | 1 |
| Hrkal, Z | 1 |
| Cajthamlová, H | 1 |
| Grebenová, D | 1 |
| Bartosová, J | 1 |
| Klamová, H | 1 |
| Marinov, J | 1 |
| Palma-Carlos, AG | 1 |
| Palma-Carlos, L | 1 |
| Lourenço, G | 1 |
| Wehmeier, A | 1 |
| Fischer, JT | 1 |
| Goerz, G | 1 |
| Schneider, W | 1 |
1 trial available for aminolevulinic acid and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Biochemical, radiologic, ultrastructural, and genetic evaluation of iron overload in acute leukemia and iron-chelation therapy.
Topics: Adolescent; Aminolevulinic Acid; Bone Marrow; Bone Marrow Cells; Child; Female; Ferritins; Hemochrom | 2014 |
4 other studies available for aminolevulinic acid and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice.
Topics: Aminolevulinic Acid; Animals; Ascites; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimula | 1999 |
[Selective photodynamic destruction of leukemic cells].
Topics: Aminolevulinic Acid; Animals; Bone Marrow Purging; Bone Marrow Transplantation; Humans; Leukemia, Ex | 2000 |
[The effect of cyclophosphamide on haem synthesis in acute myeloblastic leukaemias (author's transl)].
Topics: Aminolevulinic Acid; Anemia, Sideroblastic; Coproporphyrins; Cyclophosphamide; Erythrocytes; Glycine | 1975 |
Polychemotherapy of acute myelogenous leukemia in a patient with acute intermittent porphyria.
Topics: Acute Disease; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Chemical | 1987 |